pantoprazole and voriconazole

pantoprazole has been researched along with voriconazole in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's4 (57.14)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Akers, KS; Boyd, NK; Niece, KL1
Arwood, MJ; Bulitta, J; Cavallari, LH; Hamadeh, IS; Klinker, KP; Mangal, N; Samant, TS; Schmidt, S1
Barbeito Castiñeiras, G; Bardán García, B; Belles Medall, D; Blanco Dorado, S; Blanco Hortas, A; Campos-Toimil, M; Carracedo, Á; Fernández-Ferreiro, A; Gómez Márquez, A; Lamas, MJ; Latorre-Pellicer, A; López-Vizcaíno, A; Maroñas Amigo, O; Otero Espinar, F; Pérez Del Molino Bernal, ML; Rodríguez Jato, MT; Zarra Ferro, I1
Ding, H; Hu, L; Huang, Q; Jiang, Y; Liu, Q; Liu, S; Yin, T1

Reviews

1 review(s) available for pantoprazole and voriconazole

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

6 other study(ies) available for pantoprazole and voriconazole

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
In vitro study of the variable effects of proton pump inhibitors on voriconazole.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:9

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antifungal Agents; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Interactions; Esomeprazole; Humans; Lansoprazole; Microsomes, Liver; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Voriconazole

2015
Optimization of Voriconazole Therapy for the Treatment of Invasive Fungal Infections in Adults.
    Clinical pharmacology and therapeutics, 2018, Volume: 104, Issue:5

    Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cytochrome P-450 CYP2C19; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Female; Genotype; Humans; Invasive Fungal Infections; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Pantoprazole; Pharmacogenomic Variants; Phenotype; Proton Pump Inhibitors; Risk Assessment; Voriconazole

2018
A multicentre prospective study evaluating the impact of proton-pump inhibitors omeprazole and pantoprazole on voriconazole plasma concentrations.
    British journal of clinical pharmacology, 2020, Volume: 86, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Drug Interactions; Enzyme Inhibitors; Esomeprazole; Humans; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Voriconazole

2020
Effect of proton pump inhibitors on voriconazole concentrations in Chinese patients with malignant hematological diseases.
    European journal of clinical pharmacology, 2020, Volume: 76, Issue:6

    Topics: Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Female; Humans; Lansoprazole; Male; Molecular Docking Simulation; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Retrospective Studies; Voriconazole

2020